Some of our previous findings have shown impairment of the placenta due to the presence of cancer or some tumour factors, such as proinflammatory cytokines interleukin-6 (IL-6), interferon-gamma (IFN-γ), and tumour-necrosis factor (TNFα) [24]. This evidence concerns the gene IL6 and cancer.